Annual EBITDA
$11.38B$1.31B+13.02%
Summary
- Current Value
- As of today, ABT annual EBITDA is $11.38B, up +13.02% on
- Historical Performance
- ABT annual EBITDA is down -2.14% over the past 3 years, up +32.05% over the past 5 years
- All-Time High Comparison
- ABT annual EBITDA is currently -10.66% below its historical high of $12.74B set on
- 3-Year Low Comparison
- ABT annual EBITDA is +17.59% above its 3-year low of $9.68B reached on
- Sector Comparison
- ABT annual EBITDA is higher than 98.59% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $11.38B | +13.0% | -2.1% | +32.0% | +17.6% | |
| Quarterly EBITDA | $2.62B | -11.2% | +4.9% | -24.4% | +70.6% | |
| TTM EBITDA | $10.78B | -2.4% | +16.3% | -15.1% | +13.2% | |
| Price | $108.52 | -16.9% | +8.2% | -17.1% | +320.6% | |
| PE Ratio | 40.06 | +144.6% | +17.6% | +23.7% | +348.6% | |
| Annual Revenue | $44.33B | +5.7% | +1.6% | +28.1% | +26.1% | |
| Annual EPS | $3.72 | -51.3% | -5.0% | +48.5% | +25.6% | |
| Annual EBIT | $8.39B | +22.5% | +0.4% | +58.6% | +19.0% | |
| Annual Net Income | $6.50B | -51.3% | -5.9% | +46.1% | +40.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.63B | N/A | -2.1% |
| 5Y | $12.74B | -10.7% | |
| All | $12.74B | -10.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $9.68B | +17.6% | |
| 5Y | $8.62B | N/A | +32.0% |
| All | $386.33M | +2845.7% |
EBITDA History
FAQ
- What is the current annual EBITDA of ABT?
- As of today, ABT annual EBITDA is $11.38B
- What is 1-year change in ABT annual EBITDA?
- ABT annual EBITDA is up +13.02% year-over-year
- What is 3-year change in ABT annual EBITDA?
- ABT annual EBITDA is down -2.14% over the past 3 years
- How far is ABT annual EBITDA from its all-time high?
- ABT annual EBITDA is currently -10.66% below its historical high of $12.74B set on December 31, 2021
- How does ABT annual EBITDA rank versus sector peers?
- ABT annual EBITDA is higher than 98.59% of companies in Healthcare sector
- When is ABT next annual earnings release?
- The next annual earnings release for ABT is on
EBITDA Formula
Quarterly EBITDA
$2.62B$148.00M-5.34%
Summary
- Current Value
- As of today, ABT quarterly EBITDA is $2.62B, down -5.34% on
- Historical Performance
- ABT quarterly EBITDA is down -11.17% year-over-year, up +4.88% over the past 3 years
- All-Time High Comparison
- ABT quarterly EBITDA is currently -29.23% below its historical high of $3.71B set on
- 3-Year Low Comparison
- ABT quarterly EBITDA is +19.82% above its 3-year low of $2.19B reached on
- Sector Comparison
- ABT quarterly EBITDA is higher than 98.17% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.62B | -5.3% | -11.2% | +4.9% | -24.4% | |
| Annual EBITDA | $11.38B | – | +13.0% | -2.1% | +32.0% | |
| TTM EBITDA | $10.78B | -3.0% | -2.4% | +16.3% | -15.1% | |
| Price | $108.52 | -2.5% | -16.9% | +8.2% | -17.1% | |
| PE Ratio | 40.06 | +11.4% | +144.6% | +17.6% | +23.7% | |
| Quarterly Revenue | $13.01B | +3.3% | +14.5% | +28.3% | +19.1% | |
| Quarterly EPS | $0.53 | -0.6% | -42.1% | -35.3% | -54.7% | |
| Quarterly EBIT | $1.37B | -20.1% | -36.8% | -18.5% | -47.8% | |
| Quarterly Net Income | $920.00M | -0.9% | -42.5% | -35.7% | -56.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.16B | -17.0% | |
| 3Y | $3.16B | -17.0% | |
| 5Y | $3.71B | -29.2% | |
| All | $3.71B | -29.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.22B | +18.3% | |
| 3Y | $2.19B | +19.8% | |
| 5Y | $2.19B | +19.8% | |
| All | -$2.70B | +197.1% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ABT?
- As of today, ABT quarterly EBITDA is $2.62B
- What is ABT quarterly EBITDA most recent change?
- ABT quarterly EBITDA was down -5.34% on September 30, 2026
- What is 1-year change in ABT quarterly EBITDA?
- ABT quarterly EBITDA is down -11.17% year-over-year
- How far is ABT quarterly EBITDA from its all-time high?
- ABT quarterly EBITDA is currently -29.23% below its historical high of $3.71B set on March 31, 2022
- How does ABT quarterly EBITDA rank versus sector peers?
- ABT quarterly EBITDA is higher than 98.17% of companies in Healthcare sector
- When is ABT next earnings release?
- The next earnings release for ABT is on
EBITDA Formula
TTM EBITDA
$10.78B$330.00M-2.97%
Summary
- Current Value
- As of today, ABT TTM EBITDA is $10.78B, down -2.97% on
- Historical Performance
- ABT TTM EBITDA is down -2.44% year-over-year, up +16.28% over the past 3 years
- All-Time High Comparison
- ABT TTM EBITDA is currently -21.12% below its historical high of $13.66B set on
- 3-Year Low Comparison
- ABT TTM EBITDA is +16.28% above its 3-year low of $9.27B reached on an earlier date
- Sector Comparison
- ABT TTM EBITDA is higher than 98.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $10.78B | -3.0% | -2.4% | +16.3% | -15.1% | |
| Annual EBITDA | $11.38B | – | +13.0% | -2.1% | +32.0% | |
| Quarterly EBITDA | $2.62B | -5.3% | -11.2% | +4.9% | -24.4% | |
| Price | $108.52 | -2.5% | -16.9% | +8.2% | -17.1% | |
| PE Ratio | 40.06 | +11.4% | +144.6% | +17.6% | +23.7% | |
| TTM Revenue | $48.23B | +3.5% | +10.0% | +20.7% | +14.0% | |
| TTM EPS | $2.71 | -12.4% | -66.0% | -8.0% | -33.0% | |
| TTM EBIT | $6.87B | -10.4% | -13.3% | +13.8% | -25.1% | |
| TTM Net Income | $4.73B | -12.6% | -66.0% | -8.1% | -34.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.41B | -5.6% | |
| 3Y | $11.41B | -5.6% | |
| 5Y | $13.66B | -21.1% | |
| All | $13.66B | -21.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $10.78B | at low | |
| 3Y | $9.27B | N/A | +16.3% |
| 5Y | $9.27B | +16.3% | |
| All | -$1.44B | +849.4% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ABT?
- As of today, ABT TTM EBITDA is $10.78B
- What is ABT TTM EBITDA most recent change?
- ABT TTM EBITDA was down -2.97% on September 30, 2026
- What is 1-year change in ABT TTM EBITDA?
- ABT TTM EBITDA is down -2.44% year-over-year
- How far is ABT TTM EBITDA from its all-time high?
- ABT TTM EBITDA is currently -21.12% below its historical high of $13.66B set on June 30, 2022
- How does ABT TTM EBITDA rank versus sector peers?
- ABT TTM EBITDA is higher than 98.27% of companies in Healthcare sector
- When is ABT next earnings release?
- The next earnings release for ABT is on
EBITDA Formula
Data Sources & References
- ABT Official Website www.abbott.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
- ABT Profile on Yahoo Finance finance.yahoo.com/quote/ABT
- ABT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abt
